Metraipolis › archive › dc_fd5225c122ff

Immunometabolism: The role of gut-derived microbial metabolites in optimising immune response during checkpoint inhibitor therapy — Europe PMC PMID:40910376

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40910376
DOI
10.1002/ctm2.70472
License (as archived)
solo-consultazione
Archived
2026-11-10T05:42:46.705Z
SHA-256 of the archived text
1bc1c12a4aadfb1ab9996e701545a578f29a327ab2354a414b6d66992434bbe9
Stable URL of this page
https://metraipolis.com/documento/dc_fd5225c122ff

How to cite

Immunometabolism: The role of gut-derived microbial metabolites in optimising immune response during checkpoint inhibitor therapy — Europe PMC PMID:40910376 — Europe PMC (en), https://europepmc.org/article/MED/40910376 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd5225c122ff (Metraipolis archive dc_fd5225c122ff, sha256 1bc1c12a4aadfb1ab9996e701545a578f29a327ab2354a414b6d66992434bbe9)
BibTeX
@misc{dcfd5225c122ff,
  title = {Immunometabolism: The role of gut-derived microbial metabolites in optimising immune response during checkpoint inhibitor therapy — Europe PMC PMID:40910376},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40910376},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd5225c122ff; sha256 1bc1c12a4aadfb1ab9996e701545a578f29a327ab2354a414b6d66992434bbe9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40910376. Agents can read the archived copy with the MCP tool read_document.